Fil LTD Bristol Myers Squibb CO Transaction History

Fil LTD

$95.5 Billion
Q2 2024

A detailed history of Fil LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fil LTD holds 752,951 shares of BMY stock, worth $40 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

752,951

Previous 1,213,194 37.94%

Holding current value

$40 Million

Previous $65.8 Million 52.47%

% of portfolio

0.03%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $18.5 Million - $24.4 Million	-460,243 Reduced 37.94%	752,951 $31.3 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $310 Million - $352 Million	-6,467,971 Reduced 84.21%	1,213,194 $65.8 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $5.19 Million - $6.19 Million	107,009 Added 1.41%	7,681,165 $394 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $16.4 Million - $18.4 Million	-284,153 Reduced 3.62%	7,574,156 $440 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $151 Million - $168 Million	-2,369,363 Reduced 23.17%	7,858,309 $503 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $14.5 Million - $16.4 Million	220,578 Added 2.2%	10,227,672 $709 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $17.1 Million - $20.3 Million	250,321 Added 2.57%	10,007,094 $720 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $185,066 - $109 Million	-1,423,589 Reduced 12.73%	9,756,773 $694 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $87.9 Million - $96.9 Million	1,210,940 Added 12.15%	11,180,362 $861 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $163 Million - $195 Million	2,648,544 Added 36.18%	9,969,422 $728 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $142 Million - $166 Million	2,650,727 Added 56.76%	7,320,878 $456 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $51.1 Million - $59.8 Million	862,993 Added 22.67%	4,670,151 $276 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $6.36 Million - $6.93 Million	-102,780 Reduced 2.63%	3,807,158 $254 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $5.72 Million - $6.44 Million	-96,467 Reduced 2.41%	3,909,938 $247 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $67.6 Million - $76.6 Million	-1,170,959 Reduced 22.62%	4,006,405 $249 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $23.6 Million - $26.2 Million	411,106 Added 8.63%	5,177,364 $312 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $49 Million - $57.2 Million	893,131 Added 23.06%	4,766,258 $280 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $83.9 Million - $122 Million	-1,809,082 Reduced 31.84%	3,873,127 $216 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $126 Million - $165 Million	2,566,594 Added 82.38%	5,682,209 $365 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $124 Million - $147 Million	2,897,634 Added 1329.31%	3,115,615 $158 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $2.66 Million - $2.94 Million	-59,656 Reduced 21.49%	217,981 $9.89 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $9.18 Million - $10.9 Million	203,529 Added 274.64%	277,637 $13.2 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $121 Million - $157 Million	-2,487,496 Reduced 97.11%	74,108 $3.85 Million
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $133 Million - $150 Million	2,402,567 Added 1510.7%	2,561,604 $159 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $8.68 Million - $10.8 Million	-171,846 Reduced 51.94%	159,037 $8.8 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $11.9 Million - $13.7 Million	-198,787 Reduced 37.53%	330,883 $20.9 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $3.38 Million - $3.68 Million	-56,360 Reduced 9.62%	529,670 $32.5 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $1.97 Million - $2.27 Million	35,670 Added 6.48%	586,030 $37.4 Million
Q2 2017 Aug 29, 2017	BUY	N/A	550,360	550,360 $30.7 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account